
Amarex Biosciences India Private Limited
About Amarex Biosciences India Private Limited
Data last updated:
Amarex Biosciences India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 05 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2009PTC190969. Its GSTIN is 07AAHCA7714K1ZH (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mukesh Kumar and Rakesh Kumar Narang.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – I – 270 – B Dda Flats Kalkaji, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹75.1 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹8.46 Lakh (net margin 11.3%) and EBITDA of ₹11.45 Lakh (EBITDA margin 15.2%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Amarex Biosciences India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressL – I – 270 – B Dda Flats Kalkaji, New Delhi, Delhi, India – 110019
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Amarex Biosciences India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amarex Biosciences India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amarex Biosciences India Private Limited, buy the company report.
Financials of Amarex Biosciences India Private Limited
FY 2025 filings availableAmarex Biosciences India Private Limited reported revenue of ₹75.1 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | ||||
| Net Profit Margin | 11.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amarex Biosciences India Private Limited, buy the company report.
Board of directors of Amarex Biosciences India Private Limited
Amarex Biosciences India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar | Director | 10 Dec 2009 | 16 Years 11 Months | Current |
| Rakesh Kumar Narang | Director | 05 Jun 2009 | 17 Years 5 Months | Current |
| Anju Bala Narang | Director | 05 Jun 2009 | 17 Years 5 Months | Current |
Auditor
Amarex Biosciences India Private Limited is audited by ANAND DUA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANAND DUA & ASSOCIATES | FY 2019 | 004263N |
Shareholding
The shareholding of Amarex Biosciences India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Amarex Biosciences India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amarex Biosciences India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amarex Biosciences India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amarex Biosciences India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCA7714K1ZH | Delhi | Active | 25 Jun 2018 |
To see the full GST registrations and return filing status of Amarex Biosciences India Private Limited, buy the company report.
Recent activity
Amarex Biosciences India Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Mukesh Kumar was appointed as Director on 10 Dec 2009.
Frequently asked questions
Amarex Biosciences India is an active private limited company based in New Delhi, Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 05 June 2009 (17+ years old) and is registered under CIN U73100DL2009PTC190969.
Amarex Biosciences India has 3 current directors:
- Mukesh Kumar - Director
- Rakesh Kumar Narang - Director
- Anju Bala Narang - Director
The latest financial statements of Amarex Biosciences India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amarex Biosciences India is 07AAHCA7714K1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Amarex Biosciences India is U73100DL2009PTC190969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amarex Biosciences India was incorporated on 05 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Mukesh Kumar was appointed as Director on 10 Dec 2009. Anju Bala Narang was appointed as Director on 05 Jun 2009. Rakesh Kumar Narang was appointed as Director on 05 Jun 2009.
The registered office of Amarex Biosciences India is at L – I – 270 – B Dda Flats Kalkaji, New Delhi, Delhi, India – 110019.
Amarex Biosciences India operates in the healthcare industry, in the preventive health services segment.
The compliance status of Amarex Biosciences India is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.

